CN108245469B - Anti-aging skin care product - Google Patents
Anti-aging skin care product Download PDFInfo
- Publication number
- CN108245469B CN108245469B CN201810340299.3A CN201810340299A CN108245469B CN 108245469 B CN108245469 B CN 108245469B CN 201810340299 A CN201810340299 A CN 201810340299A CN 108245469 B CN108245469 B CN 108245469B
- Authority
- CN
- China
- Prior art keywords
- extract
- water
- oat bran
- quince
- taking
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Fee Related
Links
- 230000003712 anti-aging effect Effects 0.000 title claims abstract description 30
- 239000000284 extract Substances 0.000 claims abstract description 89
- 229940038580 oat bran Drugs 0.000 claims abstract description 48
- 244000241838 Lycium barbarum Species 0.000 claims abstract description 35
- 235000015459 Lycium barbarum Nutrition 0.000 claims abstract description 35
- 235000015468 Lycium chinense Nutrition 0.000 claims abstract description 28
- 235000013399 edible fruits Nutrition 0.000 claims abstract description 27
- 229920000036 polyvinylpyrrolidone Polymers 0.000 claims abstract description 25
- 239000001267 polyvinylpyrrolidone Substances 0.000 claims abstract description 25
- 235000013855 polyvinylpyrrolidone Nutrition 0.000 claims abstract description 25
- 229940069774 quince extract Drugs 0.000 claims abstract description 25
- 244000248557 Ophiopogon japonicus Species 0.000 claims abstract description 23
- 229930195210 Ophiopogon Natural products 0.000 claims abstract description 12
- 239000002199 base oil Substances 0.000 claims abstract description 9
- 239000002202 Polyethylene glycol Substances 0.000 claims abstract description 7
- 229920001223 polyethylene glycol Polymers 0.000 claims abstract description 7
- 229920002907 Guar gum Polymers 0.000 claims abstract description 6
- 239000000665 guar gum Substances 0.000 claims abstract description 6
- 235000010417 guar gum Nutrition 0.000 claims abstract description 6
- 229960002154 guar gum Drugs 0.000 claims abstract description 6
- 235000011399 aloe vera Nutrition 0.000 claims abstract description 4
- 239000003921 oil Substances 0.000 claims abstract description 4
- 241001116389 Aloe Species 0.000 claims abstract 2
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 81
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 claims description 58
- RTZKZFJDLAIYFH-UHFFFAOYSA-N Diethyl ether Chemical compound CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 claims description 40
- 235000017784 Mespilus germanica Nutrition 0.000 claims description 33
- 244000182216 Mimusops elengi Species 0.000 claims description 33
- 235000000560 Mimusops elengi Nutrition 0.000 claims description 33
- 235000007837 Vangueria infausta Nutrition 0.000 claims description 33
- 239000000047 product Substances 0.000 claims description 24
- 238000010438 heat treatment Methods 0.000 claims description 21
- 238000010992 reflux Methods 0.000 claims description 20
- 235000017788 Cydonia oblonga Nutrition 0.000 claims description 19
- UIIMBOGNXHQVGW-UHFFFAOYSA-M Sodium bicarbonate Chemical compound [Na+].OC([O-])=O UIIMBOGNXHQVGW-UHFFFAOYSA-M 0.000 claims description 18
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 claims description 18
- 238000004321 preservation Methods 0.000 claims description 18
- 238000000034 method Methods 0.000 claims description 17
- OENHQHLEOONYIE-UKMVMLAPSA-N all-trans beta-carotene Natural products CC=1CCCC(C)(C)C=1/C=C/C(/C)=C/C=C/C(/C)=C/C=C/C=C(C)C=CC=C(C)C=CC1=C(C)CCCC1(C)C OENHQHLEOONYIE-UKMVMLAPSA-N 0.000 claims description 16
- 235000013734 beta-carotene Nutrition 0.000 claims description 16
- TUPZEYHYWIEDIH-WAIFQNFQSA-N beta-carotene Natural products CC(=C/C=C/C=C(C)/C=C/C=C(C)/C=C/C1=C(C)CCCC1(C)C)C=CC=C(/C)C=CC2=CCCCC2(C)C TUPZEYHYWIEDIH-WAIFQNFQSA-N 0.000 claims description 16
- 239000011648 beta-carotene Substances 0.000 claims description 16
- 229960002747 betacarotene Drugs 0.000 claims description 16
- 238000001816 cooling Methods 0.000 claims description 16
- 238000001914 filtration Methods 0.000 claims description 16
- 238000004108 freeze drying Methods 0.000 claims description 16
- OENHQHLEOONYIE-JLTXGRSLSA-N β-Carotene Chemical compound CC=1CCCC(C)(C)C=1\C=C\C(\C)=C\C=C\C(\C)=C\C=C\C=C(/C)\C=C\C=C(/C)\C=C\C1=C(C)CCCC1(C)C OENHQHLEOONYIE-JLTXGRSLSA-N 0.000 claims description 16
- 239000000706 filtrate Substances 0.000 claims description 14
- 235000011869 dried fruits Nutrition 0.000 claims description 12
- 239000012528 membrane Substances 0.000 claims description 12
- 229920000168 Microcrystalline cellulose Polymers 0.000 claims description 10
- 239000008108 microcrystalline cellulose Substances 0.000 claims description 10
- 235000019813 microcrystalline cellulose Nutrition 0.000 claims description 10
- 229940016286 microcrystalline cellulose Drugs 0.000 claims description 10
- 238000006243 chemical reaction Methods 0.000 claims description 9
- 229910000030 sodium bicarbonate Inorganic materials 0.000 claims description 9
- 235000017557 sodium bicarbonate Nutrition 0.000 claims description 9
- 239000011780 sodium chloride Substances 0.000 claims description 9
- 239000004952 Polyamide Substances 0.000 claims description 8
- 239000005457 ice water Substances 0.000 claims description 8
- 239000012982 microporous membrane Substances 0.000 claims description 8
- 238000002156 mixing Methods 0.000 claims description 8
- 229920002647 polyamide Polymers 0.000 claims description 8
- 239000000843 powder Substances 0.000 claims description 8
- 238000007873 sieving Methods 0.000 claims description 8
- 239000002002 slurry Substances 0.000 claims description 8
- 235000011837 pasties Nutrition 0.000 claims description 4
- 238000003756 stirring Methods 0.000 claims description 4
- 238000007605 air drying Methods 0.000 claims description 2
- 239000010667 rosehip oil Substances 0.000 claims description 2
- 230000008901 benefit Effects 0.000 abstract description 2
- 241000220317 Rosa Species 0.000 abstract 1
- 238000012360 testing method Methods 0.000 description 18
- 230000037303 wrinkles Effects 0.000 description 13
- 239000000243 solution Substances 0.000 description 12
- 238000002835 absorbance Methods 0.000 description 10
- HHEAADYXPMHMCT-UHFFFAOYSA-N dpph Chemical compound [O-][N+](=O)C1=CC([N+](=O)[O-])=CC([N+]([O-])=O)=C1[N]N(C=1C=CC=CC=1)C1=CC=CC=C1 HHEAADYXPMHMCT-UHFFFAOYSA-N 0.000 description 9
- AZUYLZMQTIKGSC-UHFFFAOYSA-N 1-[6-[4-(5-chloro-6-methyl-1H-indazol-4-yl)-5-methyl-3-(1-methylindazol-5-yl)pyrazol-1-yl]-2-azaspiro[3.3]heptan-2-yl]prop-2-en-1-one Chemical compound ClC=1C(=C2C=NNC2=CC=1C)C=1C(=NN(C=1C)C1CC2(CN(C2)C(C=C)=O)C1)C=1C=C2C=NN(C2=CC=1)C AZUYLZMQTIKGSC-UHFFFAOYSA-N 0.000 description 7
- 230000000694 effects Effects 0.000 description 7
- 239000000523 sample Substances 0.000 description 7
- 238000010521 absorption reaction Methods 0.000 description 6
- -1 acyl radical Chemical class 0.000 description 5
- 230000009467 reduction Effects 0.000 description 5
- 238000009472 formulation Methods 0.000 description 4
- 238000005259 measurement Methods 0.000 description 4
- 239000000203 mixture Substances 0.000 description 4
- 239000008280 blood Substances 0.000 description 3
- 210000004369 blood Anatomy 0.000 description 3
- 239000006227 byproduct Substances 0.000 description 3
- 230000008859 change Effects 0.000 description 3
- 238000002474 experimental method Methods 0.000 description 3
- 235000019197 fats Nutrition 0.000 description 3
- 150000004676 glycans Chemical class 0.000 description 3
- 210000004185 liver Anatomy 0.000 description 3
- 229920001282 polysaccharide Polymers 0.000 description 3
- 239000005017 polysaccharide Substances 0.000 description 3
- 150000003254 radicals Chemical class 0.000 description 3
- 238000011160 research Methods 0.000 description 3
- 238000000926 separation method Methods 0.000 description 3
- 230000009759 skin aging Effects 0.000 description 3
- 239000012086 standard solution Substances 0.000 description 3
- 239000000126 substance Substances 0.000 description 3
- 238000002834 transmittance Methods 0.000 description 3
- 239000000341 volatile oil Substances 0.000 description 3
- 244000144927 Aloe barbadensis Species 0.000 description 2
- 235000002961 Aloe barbadensis Nutrition 0.000 description 2
- IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 description 2
- KWIUHFFTVRNATP-UHFFFAOYSA-N Betaine Natural products C[N+](C)(C)CC([O-])=O KWIUHFFTVRNATP-UHFFFAOYSA-N 0.000 description 2
- 206010011224 Cough Diseases 0.000 description 2
- 244000236931 Cydonia oblonga Species 0.000 description 2
- XEEYBQQBJWHFJM-UHFFFAOYSA-N Iron Chemical compound [Fe] XEEYBQQBJWHFJM-UHFFFAOYSA-N 0.000 description 2
- UPYKUZBSLRQECL-UKMVMLAPSA-N Lycopene Natural products CC(=C/C=C/C=C(C)/C=C/C=C(C)/C=C/C1C(=C)CCCC1(C)C)C=CC=C(/C)C=CC2C(=C)CCCC2(C)C UPYKUZBSLRQECL-UKMVMLAPSA-N 0.000 description 2
- KWIUHFFTVRNATP-UHFFFAOYSA-O N,N,N-trimethylglycinium Chemical compound C[N+](C)(C)CC(O)=O KWIUHFFTVRNATP-UHFFFAOYSA-O 0.000 description 2
- QRCTUFJCBXMBPP-UHFFFAOYSA-N Ovaliflavanone A Chemical compound O1C=2C(CC=C(C)C)=C(O)C(CC=C(C)C)=CC=2C(=O)CC1C1=CC=CC=C1 QRCTUFJCBXMBPP-UHFFFAOYSA-N 0.000 description 2
- 230000002292 Radical scavenging effect Effects 0.000 description 2
- 241000208292 Solanaceae Species 0.000 description 2
- 230000032683 aging Effects 0.000 description 2
- 229960003237 betaine Drugs 0.000 description 2
- 150000001746 carotenes Chemical class 0.000 description 2
- 235000005473 carotenes Nutrition 0.000 description 2
- 235000013325 dietary fiber Nutrition 0.000 description 2
- MGJZITXUQXWAKY-UHFFFAOYSA-N diphenyl-(2,4,6-trinitrophenyl)iminoazanium Chemical compound [O-][N+](=O)C1=CC([N+](=O)[O-])=CC([N+]([O-])=O)=C1N=[N+](C=1C=CC=CC=1)C1=CC=CC=C1 MGJZITXUQXWAKY-UHFFFAOYSA-N 0.000 description 2
- KPUWHANPEXNPJT-UHFFFAOYSA-N disiloxane Chemical class [SiH3]O[SiH3] KPUWHANPEXNPJT-UHFFFAOYSA-N 0.000 description 2
- 239000003814 drug Substances 0.000 description 2
- 238000011534 incubation Methods 0.000 description 2
- 210000003734 kidney Anatomy 0.000 description 2
- 239000007788 liquid Substances 0.000 description 2
- 210000004072 lung Anatomy 0.000 description 2
- 238000004519 manufacturing process Methods 0.000 description 2
- 239000004530 micro-emulsion Substances 0.000 description 2
- 239000000049 pigment Substances 0.000 description 2
- 238000012545 processing Methods 0.000 description 2
- 230000002035 prolonged effect Effects 0.000 description 2
- 230000001737 promoting effect Effects 0.000 description 2
- 229940088594 vitamin Drugs 0.000 description 2
- 229930003231 vitamin Natural products 0.000 description 2
- 235000013343 vitamin Nutrition 0.000 description 2
- 239000011782 vitamin Substances 0.000 description 2
- NCYCYZXNIZJOKI-UHFFFAOYSA-N vitamin A aldehyde Natural products O=CC=C(C)C=CC=C(C)C=CC1=C(C)CCCC1(C)C NCYCYZXNIZJOKI-UHFFFAOYSA-N 0.000 description 2
- OYHQOLUKZRVURQ-NTGFUMLPSA-N (9Z,12Z)-9,10,12,13-tetratritiooctadeca-9,12-dienoic acid Chemical compound C(CCCCCCC\C(=C(/C\C(=C(/CCCCC)\[3H])\[3H])\[3H])\[3H])(=O)O OYHQOLUKZRVURQ-NTGFUMLPSA-N 0.000 description 1
- BJEPYKJPYRNKOW-REOHCLBHSA-N (S)-malic acid Chemical compound OC(=O)[C@@H](O)CC(O)=O BJEPYKJPYRNKOW-REOHCLBHSA-N 0.000 description 1
- BBTIMXAYZRWPNG-UHFFFAOYSA-N 3beta,Delta4-stigmasten-3-ol Natural products C1CC2=CC(O)CCC2(C)C2C1C1CCC(C(C)CCC(CC)C(C)C)C1(C)CC2 BBTIMXAYZRWPNG-UHFFFAOYSA-N 0.000 description 1
- 208000006820 Arthralgia Diseases 0.000 description 1
- 241000345998 Calamus manan Species 0.000 description 1
- OYPRJOBELJOOCE-UHFFFAOYSA-N Calcium Chemical compound [Ca] OYPRJOBELJOOCE-UHFFFAOYSA-N 0.000 description 1
- 206010010774 Constipation Diseases 0.000 description 1
- 244000303965 Cyamopsis psoralioides Species 0.000 description 1
- 201000004624 Dermatitis Diseases 0.000 description 1
- FEWJPZIEWOKRBE-JCYAYHJZSA-N Dextrotartaric acid Chemical compound OC(=O)[C@H](O)[C@@H](O)C(O)=O FEWJPZIEWOKRBE-JCYAYHJZSA-N 0.000 description 1
- 206010012735 Diarrhoea Diseases 0.000 description 1
- 229930091371 Fructose Natural products 0.000 description 1
- RFSUNEUAIZKAJO-ARQDHWQXSA-N Fructose Chemical compound OC[C@H]1O[C@](O)(CO)[C@@H](O)[C@@H]1O RFSUNEUAIZKAJO-ARQDHWQXSA-N 0.000 description 1
- 239000005715 Fructose Substances 0.000 description 1
- 206010019345 Heat stroke Diseases 0.000 description 1
- 241000234280 Liliaceae Species 0.000 description 1
- KSIVGTKSVYIZEB-GDUJLLAZSA-N Ophiopogonin A Chemical compound O([C@@H]1[C@@H](O)[C@@H](O)[C@@H](C)O[C@H]1O[C@@H]1C[C@H](O)CC2=CC[C@H]3[C@@H]4C[C@H]5[C@@H]([C@]4(CC[C@@H]3[C@]21C)C)[C@@H]([C@]1(OC[C@H](C)CC1)O5)C)[C@@H]1O[C@@H](C)[C@H](O)[C@@H](OC(C)=O)[C@H]1O KSIVGTKSVYIZEB-GDUJLLAZSA-N 0.000 description 1
- OAICVXFJPJFONN-UHFFFAOYSA-N Phosphorus Chemical compound [P] OAICVXFJPJFONN-UHFFFAOYSA-N 0.000 description 1
- 235000004789 Rosa xanthina Nutrition 0.000 description 1
- 241000220222 Rosaceae Species 0.000 description 1
- 208000013738 Sleep Initiation and Maintenance disease Diseases 0.000 description 1
- 208000005392 Spasm Diseases 0.000 description 1
- 208000007180 Sunstroke Diseases 0.000 description 1
- FEWJPZIEWOKRBE-UHFFFAOYSA-N Tartaric acid Natural products [H+].[H+].[O-]C(=O)C(O)C(O)C([O-])=O FEWJPZIEWOKRBE-UHFFFAOYSA-N 0.000 description 1
- 206010047700 Vomiting Diseases 0.000 description 1
- 230000003213 activating effect Effects 0.000 description 1
- 239000004480 active ingredient Substances 0.000 description 1
- 210000001789 adipocyte Anatomy 0.000 description 1
- 229930013930 alkaloid Natural products 0.000 description 1
- BJEPYKJPYRNKOW-UHFFFAOYSA-N alpha-hydroxysuccinic acid Natural products OC(=O)C(O)CC(O)=O BJEPYKJPYRNKOW-UHFFFAOYSA-N 0.000 description 1
- 238000004458 analytical method Methods 0.000 description 1
- 239000003963 antioxidant agent Substances 0.000 description 1
- 230000003078 antioxidant effect Effects 0.000 description 1
- 235000006708 antioxidants Nutrition 0.000 description 1
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- 229940076810 beta sitosterol Drugs 0.000 description 1
- LGJMUZUPVCAVPU-UHFFFAOYSA-N beta-Sitostanol Natural products C1CC2CC(O)CCC2(C)C2C1C1CCC(C(C)CCC(CC)C(C)C)C1(C)CC2 LGJMUZUPVCAVPU-UHFFFAOYSA-N 0.000 description 1
- NJKOMDUNNDKEAI-UHFFFAOYSA-N beta-sitosterol Natural products CCC(CCC(C)C1CCC2(C)C3CC=C4CC(O)CCC4C3CCC12C)C(C)C NJKOMDUNNDKEAI-UHFFFAOYSA-N 0.000 description 1
- QADVIPISOOQJMJ-WLKYTNTRSA-N beta-stigmasterol Natural products CCC(CC)C=C[C@@H](C)[C@H]1CC[C@@H]2[C@@H]1CC[C@H]3[C@H]2CC=C4C[C@@H](O)CC[C@]34C QADVIPISOOQJMJ-WLKYTNTRSA-N 0.000 description 1
- 230000015572 biosynthetic process Effects 0.000 description 1
- 230000036772 blood pressure Effects 0.000 description 1
- 210000001124 body fluid Anatomy 0.000 description 1
- 239000010839 body fluid Substances 0.000 description 1
- 239000011575 calcium Substances 0.000 description 1
- 229910052791 calcium Inorganic materials 0.000 description 1
- 150000001720 carbohydrates Chemical class 0.000 description 1
- 210000004027 cell Anatomy 0.000 description 1
- 230000001413 cellular effect Effects 0.000 description 1
- HNEGQIOMVPPMNR-IHWYPQMZSA-N citraconic acid Chemical compound OC(=O)C(/C)=C\C(O)=O HNEGQIOMVPPMNR-IHWYPQMZSA-N 0.000 description 1
- 229940018557 citraconic acid Drugs 0.000 description 1
- 239000011248 coating agent Substances 0.000 description 1
- 238000000576 coating method Methods 0.000 description 1
- 235000009508 confectionery Nutrition 0.000 description 1
- 239000002537 cosmetic Substances 0.000 description 1
- 230000003247 decreasing effect Effects 0.000 description 1
- 230000005786 degenerative changes Effects 0.000 description 1
- 239000003599 detergent Substances 0.000 description 1
- 238000011161 development Methods 0.000 description 1
- 230000018109 developmental process Effects 0.000 description 1
- 206010012601 diabetes mellitus Diseases 0.000 description 1
- 206010013023 diphtheria Diseases 0.000 description 1
- 201000010099 disease Diseases 0.000 description 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 1
- 239000012153 distilled water Substances 0.000 description 1
- 208000017574 dry cough Diseases 0.000 description 1
- 201000006549 dyspepsia Diseases 0.000 description 1
- 239000003974 emollient agent Substances 0.000 description 1
- 238000004945 emulsification Methods 0.000 description 1
- 230000004438 eyesight Effects 0.000 description 1
- 229930003944 flavone Natural products 0.000 description 1
- 150000002213 flavones Chemical class 0.000 description 1
- 235000011949 flavones Nutrition 0.000 description 1
- 229930003935 flavonoid Natural products 0.000 description 1
- 235000017173 flavonoids Nutrition 0.000 description 1
- 150000002215 flavonoids Chemical class 0.000 description 1
- 239000012530 fluid Substances 0.000 description 1
- 230000007760 free radical scavenging Effects 0.000 description 1
- 230000036541 health Effects 0.000 description 1
- 238000010191 image analysis Methods 0.000 description 1
- 210000000987 immune system Anatomy 0.000 description 1
- 238000000338 in vitro Methods 0.000 description 1
- 206010022437 insomnia Diseases 0.000 description 1
- 230000000968 intestinal effect Effects 0.000 description 1
- 229910052742 iron Inorganic materials 0.000 description 1
- 230000001678 irradiating effect Effects 0.000 description 1
- KSIVGTKSVYIZEB-UHFFFAOYSA-N lirioplioside B Natural products O1C2(OCC(C)CC2)C(C)C(C2(CCC3C45C)C)C1CC2C3CC=C4CC(O)CC5OC1OC(C)C(O)C(O)C1OC1OC(C)C(O)C(OC(C)=O)C1O KSIVGTKSVYIZEB-UHFFFAOYSA-N 0.000 description 1
- 229960005375 lutein Drugs 0.000 description 1
- KBPHJBAIARWVSC-RGZFRNHPSA-N lutein Chemical compound C([C@H](O)CC=1C)C(C)(C)C=1\C=C\C(\C)=C\C=C\C(\C)=C\C=C\C=C(/C)\C=C\C=C(/C)\C=C\[C@H]1C(C)=C[C@H](O)CC1(C)C KBPHJBAIARWVSC-RGZFRNHPSA-N 0.000 description 1
- 229940074156 lycium barbarum fruit extract Drugs 0.000 description 1
- 239000001630 malic acid Substances 0.000 description 1
- 235000011090 malic acid Nutrition 0.000 description 1
- 125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 description 1
- 238000012986 modification Methods 0.000 description 1
- 230000004048 modification Effects 0.000 description 1
- 230000003020 moisturizing effect Effects 0.000 description 1
- 150000002772 monosaccharides Chemical class 0.000 description 1
- 210000003205 muscle Anatomy 0.000 description 1
- 229930014626 natural product Natural products 0.000 description 1
- 230000007935 neutral effect Effects 0.000 description 1
- 229910052757 nitrogen Inorganic materials 0.000 description 1
- 235000019198 oils Nutrition 0.000 description 1
- 229920001542 oligosaccharide Polymers 0.000 description 1
- 150000002482 oligosaccharides Chemical class 0.000 description 1
- 230000003287 optical effect Effects 0.000 description 1
- 210000000056 organ Anatomy 0.000 description 1
- 150000007524 organic acids Chemical class 0.000 description 1
- 235000005985 organic acids Nutrition 0.000 description 1
- 230000003647 oxidation Effects 0.000 description 1
- 238000007254 oxidation reaction Methods 0.000 description 1
- 229910052760 oxygen Inorganic materials 0.000 description 1
- 239000001301 oxygen Substances 0.000 description 1
- 206010033675 panniculitis Diseases 0.000 description 1
- 239000002304 perfume Substances 0.000 description 1
- 230000000144 pharmacologic effect Effects 0.000 description 1
- 210000003800 pharynx Anatomy 0.000 description 1
- 239000008055 phosphate buffer solution Substances 0.000 description 1
- 239000011574 phosphorus Substances 0.000 description 1
- 229910052698 phosphorus Inorganic materials 0.000 description 1
- 229920001296 polysiloxane Polymers 0.000 description 1
- 239000011148 porous material Substances 0.000 description 1
- 238000001314 profilometry Methods 0.000 description 1
- 230000000750 progressive effect Effects 0.000 description 1
- 235000012950 rattan cane Nutrition 0.000 description 1
- 230000008929 regeneration Effects 0.000 description 1
- 238000011069 regeneration method Methods 0.000 description 1
- 230000002040 relaxant effect Effects 0.000 description 1
- 239000010666 rose oil Substances 0.000 description 1
- 235000019719 rose oil Nutrition 0.000 description 1
- 239000012488 sample solution Substances 0.000 description 1
- 229930182490 saponin Natural products 0.000 description 1
- 235000017709 saponins Nutrition 0.000 description 1
- 150000007949 saponins Chemical class 0.000 description 1
- 229920006268 silicone film Polymers 0.000 description 1
- KZJWDPNRJALLNS-VJSFXXLFSA-N sitosterol Chemical compound C1C=C2C[C@@H](O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H]([C@H](C)CC[C@@H](CC)C(C)C)[C@@]1(C)CC2 KZJWDPNRJALLNS-VJSFXXLFSA-N 0.000 description 1
- 229950005143 sitosterol Drugs 0.000 description 1
- 231100000075 skin burn Toxicity 0.000 description 1
- 239000002904 solvent Substances 0.000 description 1
- 210000000130 stem cell Anatomy 0.000 description 1
- HCXVJBMSMIARIN-UHFFFAOYSA-N stigmasterol Chemical compound C1C=C2CC(O)CCC2(C)C2C1C1CCC(C(C)C=CC(CC)C(C)C)C1(C)CC2 HCXVJBMSMIARIN-UHFFFAOYSA-N 0.000 description 1
- BFDNMXAIBMJLBB-UHFFFAOYSA-N stigmasterol Natural products CCC(C=CC(C)C1CCCC2C3CC=C4CC(O)CCC4(C)C3CCC12C)C(C)C BFDNMXAIBMJLBB-UHFFFAOYSA-N 0.000 description 1
- 229940032091 stigmasterol Drugs 0.000 description 1
- 235000016831 stigmasterol Nutrition 0.000 description 1
- 230000000638 stimulation Effects 0.000 description 1
- 210000004304 subcutaneous tissue Anatomy 0.000 description 1
- 230000001502 supplementing effect Effects 0.000 description 1
- 235000018553 tannin Nutrition 0.000 description 1
- 239000001648 tannin Substances 0.000 description 1
- 229920001864 tannin Polymers 0.000 description 1
- 235000002906 tartaric acid Nutrition 0.000 description 1
- 239000011975 tartaric acid Substances 0.000 description 1
- 210000002435 tendon Anatomy 0.000 description 1
- 230000035922 thirst Effects 0.000 description 1
- KBPHJBAIARWVSC-XQIHNALSSA-N trans-lutein Natural products CC(=C/C=C/C=C(C)/C=C/C=C(C)/C=C/C1=C(C)CC(O)CC1(C)C)C=CC=C(/C)C=CC2C(=CC(O)CC2(C)C)C KBPHJBAIARWVSC-XQIHNALSSA-N 0.000 description 1
- 238000005303 weighing Methods 0.000 description 1
- FJHBOVDFOQMZRV-XQIHNALSSA-N xanthophyll Natural products CC(=C/C=C/C=C(C)/C=C/C=C(C)/C=C/C1=C(C)CC(O)CC1(C)C)C=CC=C(/C)C=CC2C=C(C)C(O)CC2(C)C FJHBOVDFOQMZRV-XQIHNALSSA-N 0.000 description 1
- 235000008210 xanthophylls Nutrition 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/96—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution
- A61K8/97—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution from algae, fungi, lichens or plants; from derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/72—Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds
- A61K8/73—Polysaccharides
- A61K8/737—Galactomannans, e.g. guar; Derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/72—Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds
- A61K8/81—Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds obtained by reactions involving only carbon-to-carbon unsaturated bonds
- A61K8/817—Compositions of homopolymers or copolymers of compounds having one or more unsaturated aliphatic radicals, each having only one carbon-to-carbon double bond, and at least one being terminated by a single or double bond to nitrogen or by a heterocyclic ring containing nitrogen; Compositions or derivatives of such polymers, e.g. vinylimidazol, vinylcaprolactame, allylamines (Polyquaternium 6)
- A61K8/8176—Homopolymers of N-vinyl-pyrrolidones. Compositions of derivatives of such polymers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/72—Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds
- A61K8/84—Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds obtained by reactions otherwise than those involving only carbon-carbon unsaturated bonds
- A61K8/86—Polyethers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/92—Oils, fats or waxes; Derivatives thereof, e.g. hydrogenation products thereof
- A61K8/922—Oils, fats or waxes; Derivatives thereof, e.g. hydrogenation products thereof of vegetable origin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q19/00—Preparations for care of the skin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q19/00—Preparations for care of the skin
- A61Q19/08—Anti-ageing preparations
Abstract
The invention discloses an anti-aging skin care product which comprises, by mass, 20-24% of a wolfberry fruit extract, 16-18% of an ophiopogon root extract, 10-12% of a quince extract, 5-7% of an oat bran extract, 1-2% of guar gum, 4-5% of polyvinylpyrrolidone, 4-5% of polyethylene glycol and 32-35% of base oil, wherein the base oil is selected from rose fruit oil or aloe oil, and has the advantage of anti-aging.
Description
Technical Field
The invention relates to an anti-aging skin care product.
Background
Aging refers to the progressive functional and organic degenerative changes that occur over time in an organism. The skin, like other organs of the human body, ages gradually with age, and there are a series of biological changes in the natural aging process of the skin, such as the reduction of cellular components of the skin and subcutaneous tissues and the change of the immune system. The fundamental change of skin aging is the appearance of wrinkles.
Fructus Lycii is mature fruit of Lycium barbarum L. of Solanaceae, and has effects of caring skin, removing speckle, moistening skin, and reducing weight. Mainly contains alkaloids (betaine, etc.), flavonoids, polysaccharides, pigments (carotene, xanthophyll), volatile oils, etc. The wolfberry fruit polysaccharide can eliminate oxygen free radicals, reduce lipofuscin content, delay senility, reduce blood fat, reduce fat in body, reduce fat cell volume and reduce weight, and the beta-carotene and vitamins contained in the wolfberry fruit polysaccharide have anti-aging effect. In the prior art, the medlar is absorbed in an edible way, and the development of other use forms of the medlar has certain production and application values.
Disclosure of Invention
The invention aims to provide an anti-aging skin care product which has the advantage of anti-aging.
The technical purpose of the invention is realized by the following technical scheme:
an anti-aging skin care product comprises, by mass, 20-24% of a wolfberry fruit extract, 16-18% of a dwarf lilyturf root extract, 10-12% of a quince extract, 5-7% of an oat bran extract, 1-2% of guar gum, 4-5% of polyvinylpyrrolidone, 4-5% of polyethylene glycol and 32-35% of base oil; the base oil is selected from rose hip oil or aloe vera oil.
Fructus Lycii is mature fruit of Lycium barbarum L. belonging to Solanaceae, is sweet and neutral, and enters liver and kidney channels, and has effects of nourishing liver and kidney, nourishing liver and improving eyesight. Modern medical research shows that the health care product contains carotene, betaine, multiple vitamins, calcium, phosphorus, iron and the like, has pharmacological effects of increasing cell activity and promoting stem cell regeneration, and also can reduce blood pressure, blood sugar and blood fat.
Radix Ophiopogonis is root tuber of Ophiopogon japonicus (Ophiopogon japonicus, Linn. f.) Ker-Gawl.) belonging to Liliaceae. It has effects in nourishing yin, promoting fluid production, moistening lung, and clearing heart fire, and can be used for treating dry cough due to lung dryness, cough due to consumptive disease, thirst due to body fluid consumption, vexation, insomnia, internal heat, diabetes, constipation due to intestinal dryness, and diphtheria due to pharynx. Modern medicine shows that it contains saponins (ophiopogonin A, B, C, D, etc.), flavones (ophiopogon flavanone A, B, methyl ophiopogon flavanone A, B, etc.), saccharides (monosaccharides and oligosaccharides), volatile oil, beta-sitosterol and stigmasterol.
Quince, quince Cydonia oblonga mill, a quince of the family rosaceae, is administered as a fruit. It has effects of eliminating dampness, relieving summer-heat, relaxing muscles and tendons, and activating collaterals, and can be used for treating sunstroke, emesis, diarrhea, dyspepsia, arthralgia, and gastrocnemius spasm. Modern medicine shows that it contains sugar (mainly fructose), tannin, protopectin, organic acids (malic acid, tartaric acid, citraconic acid) and volatile oil.
Oat bran contains water-soluble dietary fiber, insoluble dietary fiber, linoleic acid, etc.
By adopting the technical scheme, the base oil is used as a carrier, so that the situations of skin burn and the like caused by overhigh concentration of the extract are reduced; the combination of guar gum, polyvinylpyrrolidone and polyethylene glycol is utilized to uniformly disperse the various extracts, so that the phenomena of layering and the like are reduced; utilize mild stimulation of quince extract to the capillary, oat bran extract to the tightening effect of skin and polyvinylpyrrolidone and polyethylene glycol to the softening of skin top layer, realize opening and shutting of skin pore, promote the active ingredient in wolfberry fruit extract, other extracts, guar gum gets into the skin, the ophiopogon root extract can assist the condition that plays the skin allergy of reduction skin opening and shutting in-process simultaneously, consequently, the absorption condition of the product of this application is superior to solitary wolfberry fruit extract far away, have better emollient, moisturizing and anti-aging effect.
More preferably: the beta-carotene in the medlar extract is less than 0.05wt% of the total amount of the anti-aging skin care product.
Modern medical research shows that the beta-carotene contained in the medlar also has the anti-aging effect. However, in this scheme, the reduction of β -carotene can improve the anti-aging effect, which is also the new point of this application. The medlar in the prior art is mainly used in a form of eating, and researches show that the beta-carotene in the medlar can improve the anti-aging effect; however, in the present application, acting directly on the skin in the form of a skin care product, it is speculated that the skin has a hindering effect on its absorption, causing a phenomenon which is contrary to the teaching in the prior art.
More preferably: the wolfberry fruit extract is prepared by the following method:
(1) taking fresh fructus Lycii, air drying until the water content of fructus Lycii is not higher than 10 wt%;
(2) taking the dried medlar, adding water, and mechanically crushing to obtain medlar water slurry; the ratio of the dry weight of the medlar to the amount of the water added in the step (2) is 1: 2.0-2.2 by mass;
(3) transferring the wolfberry fruit water slurry into a reflux device, adding water, heating to 88-92 ℃, carrying out heat preservation reaction for 3.0-3.2 hours, and naturally cooling to below 30 ℃; filtering with water system microporous membrane to obtain fructus Lycii filtrate; the ratio of the dry weight of the medlar to the amount of the water added in the step (3) is 1: 1.2-1.5 by mass;
(4) heating the wolfberry fruit filtrate to 45-50 ℃, dropwise adding diethyl ether while stirring, uniformly mixing, cooling to a temperature lower than 30 ℃, standing for layering, and taking a water layer; repeating for 2-3 times; the dosage ratio of the wolfberry fruit filtrate to the ether added each time is 1: 0.05-0.10 by mass;
(5) taking the water layer, freeze-drying at-30 to-35 ℃ and under 20 to 25Pa, and concentrating to 50 to 55wt% of the initial water layer to obtain the wolfberry fruit extract.
By adopting the technical scheme, the content of beta-carotene in the obtained wolfberry extract is low, and the yield is ensured.
More preferably: in the step (3) of preparing the wolfberry fruit extract, adding microcrystalline cellulose and polyvinylpyrrolidone while adding water, heating to 75-78 ℃, and reacting for 1.3-1.5 hr under heat preservation; the weight ratio of the dry weight of the medlar and the amount of the water, the microcrystalline cellulose and the polyvinylpyrrolidone in the step (3) is 1: 1.2-1.5: 0.022-0.025: 0.030-0.033.
By adopting the technical scheme, the reaction temperature is reduced, the heat preservation time is shortened, the possibility of increasing byproducts is reduced, and the yield and/or the purity are/is improved.
More preferably: in the step (4) of preparing the medlar extract, diethyl ether is added for the first time, and sodium chloride and sodium bicarbonate are added at the same time; the dosage ratio of the ethyl ether, the sodium chloride and the sodium bicarbonate added into the medlar filtrate each time is 1: 0.05-0.10: 0.002-0.003 by mass.
By adopting the technical scheme, the micro-emulsification phenomenon during standing separation is reduced, the separation difficulty is reduced, and the yield and/or purity are/is improved.
More preferably: the radix ophiopogonis extract is prepared by the following method:
taking dried tuber roots of radix ophiopogonis, crushing, and sieving with a 50-100-mesh sieve; putting the dried root tuber powder of the dwarf lilyturf tuber into a reflux device, adding water, heating to 88-90 ℃, and reacting for 40-45 min under the condition of heat preservation; cooling to 60-62 ℃ in an ice water bath, adding ethanol, reacting for 25-30 min under heat preservation, and filtering with an organic microporous filter membrane to obtain a radix ophiopogonis extracting solution; taking the radix ophiopogonis extracting solution, freeze-drying at-10 to-15 ℃ and 10-15 Pa, and concentrating to 33-35 wt% of the amount of the initial radix ophiopogonis extracting solution to obtain the radix ophiopogonis extract;
the usage ratio of the dried root tuber of the dwarf lilyturf tuber, water and ethanol is 1: 4.5-4.8: 1.2-1.3 by mass.
More preferably: the oat bran extract is prepared by the following method:
taking dry oat bran, putting the dry oat bran into 85-97% RH, absorbing water for 12-15 hr, and extruding at 120-125 ℃ to obtain pasty oat bran; putting the pasty oat bran into a reflux device, adding water and ethanol, heating to 75-77 ℃, carrying out reflux reaction for 2.5-2.8 hr, and filtering with an organic microporous filter membrane to obtain an oat bran extract; freeze-drying oat bran extract at-10 to-15 ℃ and 10-15 Pa, and concentrating to 40-45 wt% of the amount of the initial oat bran extract to obtain an oat bran extract;
the usage ratio of the dry oat bran, water and ethanol is 1: 2.0-2.2: 3.6-3.8 by mass.
More preferably: the quince extract is prepared by the following method:
taking quince dried fruits, crushing, and sieving with a 50-100-mesh sieve; putting quince dried fruit powder into a reflux device, adding water, polyamide and polyvinylpyrrolidone, heating to 88-90 ℃, and reacting for 90-100 min in a heat preservation manner; cooling to 68-70 ℃ in an ice water bath, adding ethanol, reacting for 20-22 min under heat preservation, and filtering with an organic microporous filter membrane to obtain a quince extracting solution; taking quince extract, freeze-drying at-10 to-15 ℃ and 10-15 Pa, and concentrating until the content of the quince extract is 33-40 wt% of the initial amount to obtain quince extract;
according to the mass ratio of the quince dried fruits, the water, the polyamide, the polyvinylpyrrolidone and the ethanol is 1: 2.5-2.8: 0.020-0.022: 0.028-0.029: 3.0-3.2.
In conclusion, the invention has the following beneficial effects:
the capacity of removing free radicals is strong, and the oxidation resistance is strong; the skin wrinkle is improved obviously, and the anti-aging effect is better.
Detailed Description
The present embodiment is only for explaining the present invention, and it is not limited to the present invention, and those skilled in the art can make modifications of the present embodiment without inventive contribution as needed after reading the present specification, but all of them are protected by patent law within the scope of the present invention.
Example 1 a: a fructus Lycii extract is prepared by the following method:
(1) taking fresh medlar, and airing until the water content of the medlar is 5 wt%;
(2) taking the dried medlar, adding water, and mechanically crushing to obtain medlar water slurry; the dry weight of the medlar and the dosage of the water added in the step (2) are 1:2.0 by mass;
(3) transferring the fructus Lycii water slurry to a reflux device, adding water, microcrystalline cellulose and polyvinylpyrrolidone, heating to 75 deg.C, reacting for 1.5hr, and naturally cooling to 20 deg.C; filtering with 0.22 μm water system microporous membrane to obtain fructus Lycii filtrate; the use amount ratio of the dry weight of the medlar, the water added in the step (3), the microcrystalline cellulose and the polyvinylpyrrolidone is 1:1.5:0.022:0.030 by mass;
(4) heating fructus Lycii filtrate to 45 deg.C, adding diethyl ether while stirring, mixing, cooling to 25 deg.C, standing for layering, and collecting water layer; repeating for 2 times, adding diethyl ether for the first time, and adding sodium chloride and sodium bicarbonate; according to the mass ratio of the wolfberry fruit filtrate to the added diethyl ether, sodium chloride and sodium bicarbonate every time is 1:0.05:0.003: 0.003;
(5) freeze-drying the water layer at-30 deg.C and 25Pa, and concentrating to 50wt% of the initial water layer to obtain fructus Lycii extract.
Example 1 b: a fructus Lycii extract is prepared by the following method:
(1) taking fresh medlar, and airing until the water content of the medlar is 8 wt%;
(2) taking the dried medlar, adding water, and mechanically crushing to obtain medlar water slurry; according to the mass, the dry weight of the medlar and the dosage of the water added in the step (2) are 1: 2.2;
(3) transferring the fructus Lycii water slurry to a reflux device, adding water, microcrystalline cellulose and polyvinylpyrrolidone, heating to 78 deg.C, reacting for 1.3hr, and naturally cooling to below 28 deg.C; filtering with 0.45 μm water system microporous membrane to obtain fructus Lycii filtrate; the dry weight of the medlar and the dosage ratio of the water, the microcrystalline cellulose and the polyvinylpyrrolidone in the step (3) are 1:1.2:0.025:0.033 by mass;
(4) heating fructus Lycii filtrate to 50 deg.C, adding diethyl ether while stirring, mixing, cooling to 28 deg.C, standing for layering, and collecting water layer; repeating the steps for 3 times, and adding sodium chloride and sodium bicarbonate while adding diethyl ether for the first time; according to the mass ratio of the added ether, sodium chloride and sodium bicarbonate to the wolfberry fruit filtrate every time is 1:0.10:0.002: 0.002;
(5) freeze drying the water layer at-35 deg.C under 20Pa, and concentrating to 55wt% of the original water layer to obtain fructus Lycii extract.
Example 1 c: a kind of Lycium barbarum fruit extract is different from that in example 1a in that in step (4), diethyl ether is added for the first time and sodium chloride or sodium bicarbonate is not added. Compared with the example 1a, the microemulsion phenomenon appears when the step (4) is kept stand for separation, and the microemulsion part is difficult to separate, thereby influencing the yield and/or the purity.
Example 1 d: a kind of fructus Lycii extract, different from example 1a, in step (3), add water and not add microcrystalline cellulose or polyvinylpyrrolidone, heat up to 88 deg.C, keep warm and react for 3.2 hr. Compared to example 1a, the reaction temperature is increased, the incubation time is prolonged, and there is a possibility that by-products are increased, affecting the yield and/or purity.
Example 1 e: a kind of fructus Lycii extract, different from example 1b, in step (3), add water and not add microcrystalline cellulose or polyvinylpyrrolidone, heat up to 92 deg.C, keep warm and react for 3.0 hr. Compared to example 1b, the reaction temperature is increased, the incubation time is prolonged, and there is a possibility that by-products are increased, affecting the yield and/or purity.
Example 1 f: a fructus Lycii extract is prepared from 997.2g of the fructus Lycii extract of example 1a and 2.8g of beta-carotene by mixing.
Example 2 a: an ophiopogon root extract is prepared by the following method:
taking dried tuber of dwarf lilyturf tuber, crushing and sieving by a 100-mesh sieve; placing radix Ophiopogonis dried root tuber powder into a reflux device, adding water, heating to 88 deg.C, and reacting for 45min under heat preservation; cooling to 60 deg.C in ice water bath, adding ethanol, reacting for 30min under heat preservation, and filtering with 0.22 μm organic microporous membrane to obtain radix Ophiopogonis extract; freeze-drying radix Ophiopogonis extract at-15 deg.C under 15Pa, and concentrating to 35wt% of the original radix Ophiopogonis extract to obtain radix Ophiopogonis extract; the dosage ratio of the dried root tuber of the dwarf lilyturf tuber, water and ethanol is 1:4.5:1.2 by mass.
Example 2 b: an ophiopogon root extract is prepared by the following method:
taking dried tuber of dwarf lilyturf tuber, crushing and sieving by a 50-mesh sieve; placing radix Ophiopogonis dried root tuber powder into a reflux device, adding water, heating to 90 deg.C, and reacting for 40 min; cooling to 62 deg.C in ice water bath, adding ethanol, reacting for 25min under heat preservation, and filtering with 0.45 μm organic microporous membrane to obtain radix Ophiopogonis extract; freeze-drying radix Ophiopogonis extract at-10 deg.C under 10Pa, and concentrating to 33wt% of the original radix Ophiopogonis extract to obtain radix Ophiopogonis extract; the dosage ratio of the dried root tuber of the dwarf lilyturf tuber, water and ethanol is 1: 4.8: 1.3 by mass.
Example 3 a: an oat bran extract prepared by the following method:
taking dried oat bran, placing into 85% RH, absorbing water for 15hr, and squeezing at 120 deg.C to obtain paste oat bran; placing the paste oat bran into a reflux device, adding water and ethanol, heating to 75 deg.C, reflux reacting for 2.8hr, and filtering with 0.22 μm organic microporous membrane to obtain oat bran extract; freeze drying oat bran extract at-15 deg.C under 15Pa, and concentrating to 40wt% of original oat bran extract to obtain oat bran extract; the dosage ratio of the dry oat bran, the water and the ethanol is 1:2.0:3.6 by mass.
Example 3 b: an oat bran extract prepared by the following method:
taking dried oat bran, placing into 97% RH, absorbing water for 12hr, and squeezing at 125 deg.C to obtain paste oat bran; placing the paste oat bran into a reflux device, adding water and ethanol, heating to 77 deg.C, reflux reacting for 2.5hr, and filtering with 0.45 μm organic microporous membrane to obtain oat bran extract; freeze drying oat bran extract at-10 deg.C under 10Pa, and concentrating to 45wt% of original oat bran extract to obtain oat bran extract; the dosage ratio of the dry oat bran, the water and the ethanol is 1:2.2: 3.8 by mass.
Example 4 a: a quince extract prepared by the following method:
taking quince dried fruits, crushing, and sieving with a 100-mesh sieve; putting quince dried fruit powder into a reflux device, adding water, polyamide and polyvinylpyrrolidone, heating to 88 deg.C, and reacting for 100 min; cooling to 68 deg.C in ice water bath, adding ethanol, reacting for 22min under heat preservation, and filtering with 0.22 μm organic microporous filter membrane to obtain Cydonia oblonga extractive solution; freeze drying the quince extract at-10 deg.C and 10Pa, and concentrating to 33wt% of the original amount of quince extract to obtain quince extract; the amount ratio of the quince dried fruit, water, polyamide, polyvinylpyrrolidone and ethanol was 1:2.5:0.020:0.028:3.0 by mass.
Example 4 b: a quince extract prepared by the following method:
taking quince dried fruits, crushing, and sieving with a 50-mesh sieve; putting quince dried fruit powder into a reflux device, adding water, polyamide and polyvinylpyrrolidone, heating to 90 ℃, and reacting for 90min under heat preservation; cooling to 70 deg.C in ice water bath, adding ethanol, reacting for 20min under heat preservation, and filtering with 0.45 μm organic microporous filter membrane to obtain fructus Cydoniae Oblongae extractive solution; freeze drying the quince extract at-15 deg.C and 15Pa, and concentrating to 40wt% of the original amount of quince extract to obtain quince extract; the amount ratio of the quince dried fruit, water, polyamide, polyvinylpyrrolidone and ethanol was 1:2.8:0.022:0.029:3.2 by mass.
Example 5: an anti-aging skin care product is prepared by uniformly mixing the following components by mass:
wolfberry extract (from example 1 a) 20%, ophiopogon root extract (from example 2 a) 18%, quince extract (from example 4 a) 12%, oat bran extract (from example 3 a) 5%, guar 1%, polyvinylpyrrolidone 5%, polyethylene glycol 4% and base oil (rose oil, commercially available from guangzhou yao cosmetics limited) 35%.
Example 6: an anti-aging skin care product is prepared by uniformly mixing the following components by mass:
wolfberry extract (from example 1 b) 24%, ophiopogon root extract (from example 2 b) 16%, quince extract (from example 4 b) 10%, oat bran extract (from example 3 b) 7%, guar gum 2%, polyvinylpyrrolidone 4%, polyethylene glycol 5% and base oil (aloe vera, commercially available from Jiangxi Thailand Natural perfumes, Inc.) 32%.
Example 7: an anti-aging skin care product, which is different from example 5 in that the extract of Lycium barbarum is derived from example 1 b.
Example 8: an anti-aging skin care product, which differs from example 5 in that the extract of Lycium barbarum is derived from example 1 f.
Example 9: an anti-aging skin care product, which is different from example 5 in that the extract of Lycium barbarum is commercially available from Ci-Anthuri Biotech Co.
Example 10: an anti-aging skin care product, which is different from the anti-aging skin care product in example 5, wherein the ophiopogon root extract is commercially available from Shanxi rattan biotech GmbH.
Example 11: an anti-aging skin care product, which is different from example 5 in that quince extract is commercially available from biotechnological limited fruits in leyu, guangzhou.
Example 12: an anti-aging skin care product, which is different from the skin care product obtained in example 5, wherein the oat bran extract is commercially available from Shaanxi Fuwa Natural products Co.
Concentration test of Lycium barbarum pigment (referenced as beta-carotene) in Lycium barbarum extract
(1) Selection of wavelength
Precisely weighing 5.1mg of beta-carotene, dissolving with ethanol, fixing the volume to 100ml, and shaking up to prepare a standard solution; taking 1ml of standard solution, using ethanol to fix the volume to 10ml, shaking up, using ethanol as a blank control, scanning within the wavelength range of 200-600 nm, and determining the maximum absorption peak.
(2) Drawing of standard curve
Respectively transferring 0.1 ml, 0.2 ml, 0.3 ml, 0.4 ml and 0.5ml of the standard solution into a 10ml volumetric flask, metering the volume with ethanol, shaking up, and measuring the absorbance under the maximum absorption peak; taking the concentration of beta-carotene as abscissa and the absorbance under the maximum absorption peak as ordinate, making standard curve and fitting linearly to obtain regression equation, R of the standard curve2Is 0.9994.
(3) Sample testing
The solvent of the test object (examples 1a to 1f, commercially available) was used as a blank control, and the absorbance of the test object at the maximum absorption peak was measured to determine the concentration of β -carotene according to the regression equation.
The test results are shown in table 1. Table 1 shows that the beta-carotene is much reduced, essentially negligible, in examples 1a-1e compared to commercially available wolfberry extracts and example 1f with the addition of beta-carotene to example 1 a.
In vitro antioxidant capacity determination
The determination principle is as follows: diphenylbitter acyl radical (DPPH, C)18H12N5O6) Is a stable free radical with nitrogen as the center, and if the tested substance can remove it, it indicates that the tested substance has the function of removing hydroxyl free radical, alkyl free radical or peroxy free radical, etc. The aqueous ethanol DPPH solution is dark blue and strongly absorbs at 520nm, and the absorbance of the solution can be measured by a spectrophotometer, and after the sample is added, the absorbance is reduced due to the removal of DPPH. The ability of the test substance to scavenge DPPH can be evaluated based on the change in absorbance.
And (3) sample determination: 4ml of a pH value 6.88 standard phosphate buffer solution and 4ml of 0.1777mol/l DPPH solution are sequentially added into a 10ml test tube and are uniformly mixed; secondly, adding the sample solution to be detected, supplementing the volume to 10.00ml with distilled water, and fully and uniformly mixing; ③ measuring the absorbance at 520nm after 10 min; each group of samples was measured three times repeatedly and the average value was taken; (iv) clearance of DPPH free radical = [1- (a1-a2)/A3] × 100%; a1 represents the absorbance of DPPH solution after the reaction of adding a sample to be detected; a2 represents the absorbance of a solution containing a sample to be tested and water without DPPH; a3 represents the absorbance of a solution of DPPH and water alone, without the test sample.
The results are shown in Table 2. Table 2 shows that (1) examples 5-12 have a higher DPPH radical scavenging rate than commercially available wolfberry extracts and example 1a, preferably in combination with the components of the present application; ② example 5 has higher DPPH free radical scavenging rate compared to example 8 and example 9, which shows that under the formulation of the present application, the beta-carotene in the medlar extract is preferably less than 0.05wt% (0.056 wt% in example 8, 0.1902wt% in example 9) of the total amount of an anti-aging skin care product; ③ example 5 has a higher DPPH radical scavenging rate than examples 10-12, indicating that the ophiopogon root extract, quince extract and oat bran extract prepared according to the present invention are preferably used in the formulation according to the present application.
Measurement of wrinkles on human skin
The important characteristic of skin aging in the formation of wrinkles, and the measurement of skin wrinkles, is important for judging the degree of skin aging. The present application employs profilometry (indirect measurement).
The test principle is as follows: firstly, a silicone film is made of silicone liquid, and an inverse copy of a skin wrinkle with a specific shape on the skin of a subject is obtained, wherein the part with the wrinkle on the film is convex, and the part without the wrinkle is concave. When a beam of light with specific wavelength irradiates the film, the light transmittance of the convex part is small, the light transmittance of the concave part is large, and the degree of wrinkles is judged and quantified according to the light transmittance. During measurement, light signals of different parts of the membrane are collected by a CCD camera lens, a three-dimensional image of the skin can be obtained through photoelectric and digital processing, and then the parameters of different skin wrinkles can be obtained through analysis by special software.
The testing steps are as follows: firstly, selecting effective volunteers with the age of 25-35 years (except for pregnant or lactating women), wherein the test environment temperature is 20-22 ℃, and the test environment humidity is 40% -60%; selecting a skin wrinkle tester SV600 produced by German CK company and correcting the tester; thirdly, before the experiment, a test subject uses a uniform mild detergent to clean a test part (face), a square experiment area with the size of 3cm multiplied by 3cm and symmetrical position is marked on the tested part, the experiment area is numbered, and a test area and a blank contrast are randomly marked; fourthly, coating siloxane liquid on the skin to prepare a siloxane membrane to obtain an inverse copy of the skin wrinkles of the test area and the blank control area on the skin of the detected person; irradiating the membrane with light with certain wavelength by using an image analysis tester, collecting optical signals of different parts of the membrane by using a CCD camera lens, performing photoelectric and digital processing to obtain a three-dimensional image of the skin, and analyzing by using self-contained software to obtain the average roughness (Rz) and the maximum roughness (Rm). Smearing samples in the test area respectively, and testing the data of using the samples for 0 day, 30 days and 180 days, wherein each smearing is 2ml, and each smearing is performed once a day; each sample corresponds to 10 subjects and the results are averaged.
The results are shown in Table 3. Table 3 shows that (i) both the average roughness (Rz) and the maximum roughness (Rm) were increased using example 1a, and (ii) both the average roughness (Rz) and the maximum roughness (Rm) were decreased using examples 5-12, indicating that the present application can function to reduce wrinkles; ② example 5 has a greater reduction in average roughness (Rz) and maximum roughness (Rm) than example 8 and example 9, indicating that under the formulations of the present application, preferably β -carotene in wolfberry extract is less than 0.05wt% of the total amount of an anti-aging skin care product (0.056 wt% in example 8, 0.1902wt% in example 9); ③ example 5 had a greater reduction in average roughness (Rz) and maximum roughness (Rm) than in examples 10-12, indicating that the ophiopogon root extract, quince extract and oat bran extract prepared herein are preferred for use in the formulations herein.
Claims (3)
1. An anti-aging skin care product is characterized by comprising 20-24% of a wolfberry fruit extract, 16-18% of an ophiopogon root extract, 10-12% of a quince extract, 5-7% of an oat bran extract, 1-2% of guar gum, 4-5% of polyvinylpyrrolidone, 4-5% of polyethylene glycol and 32-35% of base oil by mass; the base oil is selected from rose hip oil or aloe oil;
the beta-carotene in the medlar extract is less than 0.05wt percent of the total weight of the anti-aging skin care product; the wolfberry fruit extract is prepared by the following method:
(1) taking fresh fructus Lycii, air drying until the water content of fructus Lycii is not higher than 10 wt%; (2) taking the dried medlar, adding water, and mechanically crushing to obtain medlar water slurry; the ratio of the dry weight of the medlar to the amount of the water added in the step (2) is 1: 2.0-2.2 by mass; (3) transferring the wolfberry fruit water slurry into a reflux device, adding water, heating to 88-92 ℃, carrying out heat preservation reaction for 3.0-3.2 hours, and naturally cooling to below 30 ℃; filtering with water system microporous membrane to obtain fructus Lycii filtrate; the ratio of the dry weight of the medlar to the amount of the water added in the step (3) is 1: 1.2-1.5 by mass; (4) heating the wolfberry fruit filtrate to 45-50 ℃, dropwise adding diethyl ether while stirring, uniformly mixing, cooling to a temperature lower than 30 ℃, standing for layering, and taking a water layer; repeating for 2-3 times; the dosage ratio of the wolfberry fruit filtrate to the ether added each time is 1: 0.05-0.10 by mass; (5) taking a water layer, freeze-drying at-30 to-35 ℃ and under 20-25 Pa, and concentrating to 50-55 wt% of the initial water layer to obtain a wolfberry fruit extract;
the radix ophiopogonis extract is prepared by the following method: taking dried tuber roots of radix ophiopogonis, crushing, and sieving with a 50-100-mesh sieve; putting the dried root tuber powder of the dwarf lilyturf tuber into a reflux device, adding water, heating to 88-90 ℃, and reacting for 40-45 min under the condition of heat preservation; cooling to 60-62 ℃ in an ice water bath, adding ethanol, reacting for 25-30 min under heat preservation, and filtering with an organic microporous filter membrane to obtain a radix ophiopogonis extracting solution; taking the radix ophiopogonis extracting solution, freeze-drying at-10 to-15 ℃ and 10-15 Pa, and concentrating to 33-35 wt% of the amount of the initial radix ophiopogonis extracting solution to obtain the radix ophiopogonis extract; the using amount ratio of the dried root tuber of the dwarf lilyturf to water to ethanol is 1: 4.5-4.8: 1.2-1.3 by mass;
the oat bran extract is prepared by the following method: taking dry oat bran, putting the dry oat bran into 85-97% RH, absorbing water for 12-15 hr, and extruding at 120-125 ℃ to obtain pasty oat bran; putting the pasty oat bran into a reflux device, adding water and ethanol, heating to 75-77 ℃, carrying out reflux reaction for 2.5-2.8 hr, and filtering with an organic microporous filter membrane to obtain an oat bran extract; freeze-drying oat bran extract at-10 to-15 ℃ and 10-15 Pa, and concentrating to 40-45 wt% of the amount of the initial oat bran extract to obtain an oat bran extract; according to the mass ratio of the dry oat bran to the water to the ethanol is 1: 2.0-2.2: 3.6-3.8;
the quince extract is prepared by the following method: taking quince dried fruits, crushing, and sieving with a 50-100-mesh sieve; putting quince dried fruit powder into a reflux device, adding water, polyamide and polyvinylpyrrolidone, heating to 88-90 ℃, and reacting for 90-100 min in a heat preservation manner; cooling to 68-70 ℃ in an ice water bath, adding ethanol, reacting for 20-22 min under heat preservation, and filtering with an organic microporous filter membrane to obtain a quince extracting solution; taking quince extract, freeze-drying at-10 to-15 ℃ and 10-15 Pa, and concentrating until the content of the quince extract is 33-40 wt% of the initial amount to obtain quince extract; according to the mass ratio of the quince dried fruits, the water, the polyamide, the polyvinylpyrrolidone and the ethanol is 1: 2.5-2.8: 0.020-0.022: 0.028-0.029: 3.0-3.2.
2. The anti-aging skin care product according to claim 1, wherein in the step (3) of preparing the wolfberry fruit extract, water is added, microcrystalline cellulose and polyvinylpyrrolidone are added, the temperature is raised to 75-78 ℃, and the reaction is carried out for 1.3-1.5 hr; the weight ratio of the dry weight of the medlar and the amount of the water, the microcrystalline cellulose and the polyvinylpyrrolidone in the step (3) is 1: 1.2-1.5: 0.022-0.025: 0.030-0.033.
3. The anti-aging skin care product according to claim 1 or 2, wherein in the step (4) of preparing the wolfberry fruit extract, the diethyl ether is added for the first time and the sodium chloride and the sodium bicarbonate are added at the same time; the dosage ratio of the ethyl ether, the sodium chloride and the sodium bicarbonate added into the medlar filtrate each time is 1: 0.05-0.10: 0.002-0.003 by mass.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201810340299.3A CN108245469B (en) | 2018-04-17 | 2018-04-17 | Anti-aging skin care product |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201810340299.3A CN108245469B (en) | 2018-04-17 | 2018-04-17 | Anti-aging skin care product |
Publications (2)
Publication Number | Publication Date |
---|---|
CN108245469A CN108245469A (en) | 2018-07-06 |
CN108245469B true CN108245469B (en) | 2021-06-11 |
Family
ID=62748430
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201810340299.3A Expired - Fee Related CN108245469B (en) | 2018-04-17 | 2018-04-17 | Anti-aging skin care product |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN108245469B (en) |
Citations (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN102366478A (en) * | 2011-11-14 | 2012-03-07 | 四川逢春制药有限公司 | Composition for whitening skin and resisting senescence, preparation method and application thereof |
CN104414895A (en) * | 2013-08-23 | 2015-03-18 | 无限极(中国)有限公司 | Plant composition with moisturizing, anti-wrinkle and irritability-relieving effect and preparation method thereof |
CN105878133A (en) * | 2016-06-12 | 2016-08-24 | 马殿伟 | Cistanche-deserticola-containing whitening traditional Chinese medicine composition for cosmetics |
CN106727136A (en) * | 2016-12-27 | 2017-05-31 | 广东芭薇生物科技股份有限公司 | A kind of composition containing seed extract and preparation method thereof |
-
2018
- 2018-04-17 CN CN201810340299.3A patent/CN108245469B/en not_active Expired - Fee Related
Patent Citations (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN102366478A (en) * | 2011-11-14 | 2012-03-07 | 四川逢春制药有限公司 | Composition for whitening skin and resisting senescence, preparation method and application thereof |
CN104414895A (en) * | 2013-08-23 | 2015-03-18 | 无限极(中国)有限公司 | Plant composition with moisturizing, anti-wrinkle and irritability-relieving effect and preparation method thereof |
CN105878133A (en) * | 2016-06-12 | 2016-08-24 | 马殿伟 | Cistanche-deserticola-containing whitening traditional Chinese medicine composition for cosmetics |
CN106727136A (en) * | 2016-12-27 | 2017-05-31 | 广东芭薇生物科技股份有限公司 | A kind of composition containing seed extract and preparation method thereof |
Also Published As
Publication number | Publication date |
---|---|
CN108245469A (en) | 2018-07-06 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN103127269A (en) | Extractive of Chinese herbal compound and cosmetics including active ingredients | |
CN101822630A (en) | Nostoc sphaeroids kutz extractive and application thereof in cosmetics | |
CN104622740B (en) | Purposes of the Horse chest Nut P.E in cosmeceutical is prepared | |
CN106580778A (en) | Macadamia nut green peel extract, cosmetics employing same as active ingredient and preparation method of macadamia nut green peel extract | |
CN105816413A (en) | Black barbary wolfberry fruit procyanidine mask powder and preparation method thereof | |
CN106551870A (en) | A kind of compositionss with crease-resistant skin lightening effect, facial film and preparation method thereof | |
CN112569151B (en) | Anti-allergy repairing barrier composition and preparation method and application thereof | |
CN108703931B (en) | Composition with moisturizing effect and preparation method thereof | |
CN108815081A (en) | A kind of sericin whitening moisturizing face masque liquid and preparation method thereof | |
CN105919106A (en) | Lycium ruthenicum procyanidine oral liquid and preparation method thereof | |
CN107510647B (en) | Anti-hair loss shampoo and preparation method thereof | |
CN110742843B (en) | Anti-aging traditional Chinese medicine extract of ginseng and glossy ganoderma as well as preparation method and application thereof | |
CN107115448B (en) | Traditional Chinese medicine composition with whitening and anti-aging effects and preparation method and application thereof | |
CN102048984A (en) | Blood tonifying tablets and preparation method thereof | |
CN102266452A (en) | Chinese medicinal composition for enhancing anoxia endurance and preparation method and application thereof | |
CN108324647B (en) | Skin care emulsion and preparation method thereof | |
CN108245469B (en) | Anti-aging skin care product | |
CN114886834B (en) | Whitening essence and preparation method thereof | |
CN111803413A (en) | Noni SOD skin care product and preparation method thereof | |
CN103251802A (en) | Appearance paste and preparation method thereof | |
CN103432192A (en) | Composition with slimming function | |
CN113116801A (en) | Composition for improving skin sub-health state and preparation method thereof | |
CN113952419B (en) | Pharmaceutical composition for chronic renal failure and preparation method and application thereof | |
CN113057917B (en) | Abelmoschus manihot anti-aging composition and preparation method and application thereof | |
CN114146044A (en) | Sodium hyaluronate essence and preparation method thereof |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PB01 | Publication | ||
PB01 | Publication | ||
SE01 | Entry into force of request for substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
TA01 | Transfer of patent application right |
Effective date of registration: 20210525 Address after: 518000 room 505, 5th floor, building 105, Liantang first industrial zone, 72 Guowei Road, Xianhu community, Liantang street, Luohu District, Shenzhen City, Guangdong Province Applicant after: Shenzhen zhongdaomei Biotechnology Co.,Ltd. Address before: 350000 59 Fengting Road, Pingchuan Town, Wuping County, Longyan City, Fujian Province Applicant before: Liu Ruifang |
|
TA01 | Transfer of patent application right | ||
GR01 | Patent grant | ||
GR01 | Patent grant | ||
CF01 | Termination of patent right due to non-payment of annual fee |
Granted publication date: 20210611 |
|
CF01 | Termination of patent right due to non-payment of annual fee |